HOU Qiao-mei, GAO Chan, JIANG Shan-shan. Predictive value of different scoring systems for the risk of acute on chronic liver failure in patients with chronic hepatitis B[J]. Chinese Hepatolgy, 2020, 25(7): 749-751.
[1] 庄辉. 再论提高我国乙型肝炎治疗的可及性. 中华肝脏病杂志, 2016, 24:401-402. [2] 中华医学会肝病学分会. 慢性乙型肝炎诊断标准(2015年版). 中西医结合肝病杂志, 2015, 25:384-384. [3] 中华医学会感染病学分会肝衰竭与人工肝学组. 肝衰竭诊疗指南. 中华临床感染病杂志, 2008, 45:1053-1056. [4] Malinchoc M, Kamath P S, Gordon F D, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.. Hepatology, 2000, 31:864-871. [5] Bajaj J S, O'Leary J G, Reddy K R, et al. In-hospital mortality in cirrhosis is related to nosocomial infections independent of Meld score: the north American consortium for the study of end-stage liver disease (nacseld) study. J Hepatol, 2012, 56:S242-S242. [6] Luca A, Angermayr B, Bertolini G, et al. An integrated MELD model including serum sodium, and age improves the prediction of early mortality in patients with cirrhosis. Liver Transplant, 2007, 39:A33-A33. [7] Garritsen R, Tintu A, Metselaar H, et al. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores. Liver Transplant, 2010, 15:300-305. [8] 殷胜禄. SOFA评分联合降钙素原在脓毒症早期诊断及预后应用. 中华医院感染学杂志, 2013, 23:2536-2538. [9] 李晨, 游绍莉, 刘鸿凌, 等. 基线MELD、MELD-Na、iMELD3种模型对乙型肝炎病毒相关慢加急性肝衰竭患者近期预后的评估价值. 中华危重病急救医学, 2014, 26:539-543.